"use strict";(self.webpackChunkngsw_docs_cnv_en=self.webpackChunkngsw_docs_cnv_en||[]).push([[2115],{3905:function(e,t,n){n.d(t,{Zo:function(){return A},kt:function(){return d}});var a=n(67294);function i(e,t,n){return t in e?Object.defineProperty(e,t,{value:n,enumerable:!0,configurable:!0,writable:!0}):e[t]=n,e}function l(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var a=Object.getOwnPropertySymbols(e);t&&(a=a.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,a)}return n}function r(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?l(Object(n),!0).forEach((function(t){i(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):l(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}function o(e,t){if(null==e)return{};var n,a,i=function(e,t){if(null==e)return{};var n,a,i={},l=Object.keys(e);for(a=0;a<l.length;a++)n=l[a],t.indexOf(n)>=0||(i[n]=e[n]);return i}(e,t);if(Object.getOwnPropertySymbols){var l=Object.getOwnPropertySymbols(e);for(a=0;a<l.length;a++)n=l[a],t.indexOf(n)>=0||Object.prototype.propertyIsEnumerable.call(e,n)&&(i[n]=e[n])}return i}var s=a.createContext({}),p=function(e){var t=a.useContext(s),n=t;return e&&(n="function"==typeof e?e(t):r(r({},t),e)),n},A=function(e){var t=p(e.components);return a.createElement(s.Provider,{value:t},e.children)},m={inlineCode:"code",wrapper:function(e){var t=e.children;return a.createElement(a.Fragment,{},t)}},c=a.forwardRef((function(e,t){var n=e.components,i=e.mdxType,l=e.originalType,s=e.parentName,A=o(e,["components","mdxType","originalType","parentName"]),c=p(n),d=i,h=c["".concat(s,".").concat(d)]||c[d]||m[d]||l;return n?a.createElement(h,r(r({ref:t},A),{},{components:n})):a.createElement(h,r({ref:t},A))}));function d(e,t){var n=arguments,i=t&&t.mdxType;if("string"==typeof e||i){var l=n.length,r=new Array(l);r[0]=c;var o={};for(var s in t)hasOwnProperty.call(t,s)&&(o[s]=t[s]);o.originalType=e,o.mdxType="string"==typeof e?e:i,r[1]=o;for(var p=2;p<l;p++)r[p]=n[p];return a.createElement.apply(null,r)}return a.createElement.apply(null,n)}c.displayName="MDXCreateElement"},2407:function(e,t,n){n.r(t),n.d(t,{frontMatter:function(){return o},contentTitle:function(){return s},metadata:function(){return p},toc:function(){return A},default:function(){return c}});var a=n(87462),i=n(63366),l=(n(67294),n(3905)),r=["components"],o={sidebar_position:1,sidebar_label:"Report Templates"},s="Report Templates",p={unversionedId:"settings/report-templates/report-templates",id:"settings/report-templates/report-templates",isDocsHomePage:!1,title:"Report Templates",description:"If you want the sample analysis results to be presented as a structured report with the information you need,",source:"@site/docs/settings/report-templates/report-templates.mdx",sourceDirName:"settings/report-templates",slug:"/settings/report-templates/report-templates",permalink:"/ngsw-docs-en/settings/report-templates/report-templates",tags:[],version:"current",sidebarPosition:1,frontMatter:{sidebar_position:1,sidebar_label:"Report Templates"},sidebar:"tutorialSidebar",previous:{title:"Main Settings Presets",permalink:"/ngsw-docs-en/settings/settings/main-presets"},next:{title:"Main Report Templates",permalink:"/ngsw-docs-en/settings/report-templates/main-templates"}},A=[{value:"Add report template",id:"add-template",children:[]},{value:"Add block to report template",id:"add-block",children:[]},{value:"Block types",id:"block-types",children:[{value:"1. Section",id:"section",children:[]},{value:"2. Patient info",id:"patient-info",children:[]},{value:"3. Sample info",id:"sample-info",children:[]},{value:"4. Control (normal) sample info",id:"control-sample-info",children:[]},{value:"5. Formatted text",id:"formatted-text",children:[]},{value:"6. Disclaimer",id:"disclaimer",children:[]},{value:"7. Sign place",id:"sign-place",children:[]},{value:"8. SNVs/Indels selected by user for reports",id:"added-to-report",children:[]},{value:"9. Pinned SNVs/Indels",id:"pinned-variants",children:[]},{value:"10. SNVs/Indels suitable for the specified conditions",id:"suitable-variants",children:[]},{value:"11. CNVs suitable for the specified conditions",id:"suitable-cnvs",children:[]},{value:"12. Immunotherapy markers",id:"immunotherapy-markers",children:[]},{value:"13. Clinical trials",id:"clinical-trials",children:[]},{value:"14. SNVs/Indels in ACMG SF genes",id:"acmg-sf",children:[]},{value:"15. Glioma: Tier I variants",id:"glioma-tier1",children:[]},{value:"16. Glioma: Tier II variants",id:"glioma-tier2",children:[]},{value:"17. Glioma: Tier III variants",id:"glioma-tier3",children:[]},{value:"18. Glioma: Suggested diagnosis",id:"glioma-diagnosis",children:[]},{value:"19. Glioma: Suggested drugs",id:"suggested-drugs",children:[]},{value:"20. Glioma: Mutations details",id:"mutation-details",children:[]},{value:"21. Glioma: Glioma genes panel details",id:"gene-panel-details",children:[]},{value:"22. Glioma: Germline pathogenic for gliomas",id:"glioma-germline-pathogenic-variants",children:[]},{value:"23. Glioma: Germline pathogenic for any other diseases",id:"no-glioma-germline-pathogenic-variants",children:[]},{value:"24. Glioma: Germline glioma associated",id:"glioma-associated-germline-pathogenic-variants",children:[]},{value:"25. Glioma: Literature",id:"references",children:[]},{value:"26. Germline CNV: results",id:"cnv-results",children:[]},{value:"27. Germline CNV: interpretation",id:"cnv-interpretation",children:[]},{value:"28. Onco: Onco relevant SNVs/Indels selected by user for reports",id:"onco-variants",children:[]},{value:"29. Onco: Clinical Guidelines for onco relevant SNVs/Indels selected by user for reports",id:"clinical-recommendations",children:[]},{value:"30. Polygenic traits",id:"polygenic-traits",children:[]},{value:"31. SNVs/Indels by ClinVar phenotypes",id:"clinvar-phenotype",children:[]},{value:"32. Pharmacogenetic",id:"pharmacogenetics",children:[]}]},{value:"Edit report template",id:"edit-template",children:[{value:"Template block",id:"template-block",children:[]}]},{value:"Export report template",id:"export-template",children:[]},{value:"Import report template",id:"import-template",children:[]},{value:"Delete report template",id:"delete-template",children:[]},{value:"About a report generation",id:"report-generation",children:[]}],m={toc:A};function c(e){var t=e.components,o=(0,i.Z)(e,r);return(0,l.kt)("wrapper",(0,a.Z)({},m,o,{components:t,mdxType:"MDXLayout"}),(0,l.kt)("h1",{id:"report-templates"},"Report Templates"),(0,l.kt)("p",null,'If you want the sample analysis results to be presented as a structured report with the information you need,\nyou can create, import or edit the report template on the "Report templates" page.'),(0,l.kt)("div",{className:"admonition admonition-info alert alert--info"},(0,l.kt)("div",{parentName:"div",className:"admonition-heading"},(0,l.kt)("h5",{parentName:"div"},(0,l.kt)("span",{parentName:"h5",className:"admonition-icon"},(0,l.kt)("svg",{parentName:"span",xmlns:"http://www.w3.org/2000/svg",width:"14",height:"16",viewBox:"0 0 14 16"},(0,l.kt)("path",{parentName:"svg",fillRule:"evenodd",d:"M7 2.3c3.14 0 5.7 2.56 5.7 5.7s-2.56 5.7-5.7 5.7A5.71 5.71 0 0 1 1.3 8c0-3.14 2.56-5.7 5.7-5.7zM7 1C3.14 1 0 4.14 0 8s3.14 7 7 7 7-3.14 7-7-3.14-7-7-7zm1 3H6v5h2V4zm0 6H6v2h2v-2z"}))),"info")),(0,l.kt)("div",{parentName:"div",className:"admonition-content"},(0,l.kt)("p",{parentName:"div"},"The number and type of report templates depends on the initial settings made by the System administrator."))),(0,l.kt)("p",null,'To open the section with report templates, go to the "',(0,l.kt)("strong",{parentName:"p"},"Report templates"),'" page from the section "Settings"\nvia the navigation panel on the left:'),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(68687).Z,width:"900"})),(0,l.kt)("h2",{id:"add-template"},"Add report template"),(0,l.kt)("p",null,"Click on ",(0,l.kt)("img",{src:n(12233).Z,width:"170"})," to open the page of adding a report\ntemplate:"),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(4426).Z,width:"900"})),(0,l.kt)("p",null,"You can fill in the following fields on the page:"),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},'"Name" (gives a title to ',(0,l.kt)("a",{href:"/results/results"},"the report tab")," on the sample page). Required to fill in."),(0,l.kt)("li",{parentName:"ol"},'"Applicable to samples" is the type of samples (Any, Tumor, or Normal) to which the template will be applicable.')),(0,l.kt)("div",{className:"admonition admonition-caution alert alert--warning"},(0,l.kt)("div",{parentName:"div",className:"admonition-heading"},(0,l.kt)("h5",{parentName:"div"},(0,l.kt)("span",{parentName:"h5",className:"admonition-icon"},(0,l.kt)("svg",{parentName:"span",xmlns:"http://www.w3.org/2000/svg",width:"16",height:"16",viewBox:"0 0 16 16"},(0,l.kt)("path",{parentName:"svg",fillRule:"evenodd",d:"M8.893 1.5c-.183-.31-.52-.5-.887-.5s-.703.19-.886.5L.138 13.499a.98.98 0 0 0 0 1.001c.193.31.53.501.886.501h13.964c.367 0 .704-.19.877-.5a1.03 1.03 0 0 0 .01-1.002L8.893 1.5zm.133 11.497H6.987v-2.003h2.039v2.003zm0-3.004H6.987V5.987h2.039v4.006z"}))),"caution")),(0,l.kt)("div",{parentName:"div",className:"admonition-content"},(0,l.kt)("p",{parentName:"div"},'The value of the "Applicable to samples" field cannot be changed after the template has been saved.\nChoose the type you need during adding. The values of all other fields can be changed at any time.'))),(0,l.kt)("ol",{start:3},(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("p",{parentName:"li"},'"Active": if the toggle is on ',(0,l.kt)("img",{src:n(47910).Z,width:"35"}),', then the template will be active , i.e. will be applicable to all samples with the type corresponding to the one selected in the "Applicable to samples" field; if the toggle is off ',(0,l.kt)("img",{src:n(91836).Z,width:"35"}),", then the template will be inactive, i.e. will\nnot be applied to any uploaded sample.")),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("p",{parentName:"li"},'"Report title".')),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("p",{parentName:"li"},'"Report description" (displayed under the title on the report page).'))),(0,l.kt)("p",null,"Fill in all required fields and click\non ",(0,l.kt)("img",{src:n(11258).Z,width:"150"})," to save the template. If you leave the page by clicking on ",(0,l.kt)("img",{src:n(82901).Z,width:"150"}),"\nor otherwise, the template will not be saved. The saved template page looks like this:"),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(88928).Z,width:"900"})),(0,l.kt)("h2",{id:"add-block"},"Add block to report template"),(0,l.kt)("p",null,"To add a block to the report template, click on the search box and select the block type you need from the opened list\n(block types are detailed below):"),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(49072).Z,width:"900"})),(0,l.kt)("p",null,"After selecting the block type, fill in all the required fields\nand click on ",(0,l.kt)("img",{src:n(37321).Z,width:"160"}),". To cancel block type selection, click on ",(0,l.kt)("img",{src:n(82901).Z,width:"150"}),"."),(0,l.kt)("h2",{id:"block-types"},"Block types"),(0,l.kt)("p",null,"Each of the blocks described below can be added to the report template and includes a description of\nits specific features."),(0,l.kt)("h3",{id:"section"},"1. Section"),(0,l.kt)("p",null,"A block with a heading and description of the report section."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required).\nIf there are multiple sections in the report, they are numbered automatically."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("h3",{id:"patient-info"},"2. Patient info"),(0,l.kt)("p",null,"A block containing information about the patient associated with the sample."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Display fields:")," Check the boxes next to the fields you want to include in the report.\nAfter selecting all necessary fields, click outside the editing area to save your changes."),(0,l.kt)("ul",null,(0,l.kt)("li",{parentName:"ul"},"Patient ID;"),(0,l.kt)("li",{parentName:"ul"},"First name;"),(0,l.kt)("li",{parentName:"ul"},"Last name;"),(0,l.kt)("li",{parentName:"ul"},"Middle name;"),(0,l.kt)("li",{parentName:"ul"},"Date of birth;"),(0,l.kt)("li",{parentName:"ul"},"Age;"),(0,l.kt)("li",{parentName:"ul"},"Sex;"),(0,l.kt)("li",{parentName:"ul"},"Diagnosis;"),(0,l.kt)("li",{parentName:"ul"},"Date of diagnosis;"),(0,l.kt)("li",{parentName:"ul"},"Comments.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#patient-info"},"Patient Info"),"."),(0,l.kt)("h3",{id:"sample-info"},"3. Sample info"),(0,l.kt)("p",null,"A block containing information about the analyzed sample for which the report was generated."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Display fields:")," Check the boxes next to the fields you want to include in the report.\nAfter selecting all necessary fields, click outside the editing area to save your changes."),(0,l.kt)("ul",null,(0,l.kt)("li",{parentName:"ul"},"Sample name - the sample file name without the extension;"),(0,l.kt)("li",{parentName:"ul"},"Sample type;"),(0,l.kt)("li",{parentName:"ul"},"Sequencing type;"),(0,l.kt)("li",{parentName:"ul"},"Sample collection date;"),(0,l.kt)("li",{parentName:"ul"},"Capture kit;"),(0,l.kt)("li",{parentName:"ul"},"Sample location;"),(0,l.kt)("li",{parentName:"ul"},"Methodology;"),(0,l.kt)("li",{parentName:"ul"},"Oncological disease;"),(0,l.kt)("li",{parentName:"ul"},"Onco stage;"),(0,l.kt)("li",{parentName:"ul"},"Onco stage details;"),(0,l.kt)("li",{parentName:"ul"},"Therapy line;"),(0,l.kt)("li",{parentName:"ul"},"Comments.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#tumor-sample-info"},"Tumor Sample Info"),"."),(0,l.kt)("h3",{id:"control-sample-info"},"4. Control (normal) sample info"),(0,l.kt)("p",null,"This block contains information about a non-tumor sample that corresponds to a tumor sample in a tumor/control pair.\nIt is generated only for tumor samples."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Display fields:"),' the same fields as in the "Sample info" block.\nCheck the boxes next to the fields you want to include in the report.\nAfter selecting all necessary fields, click outside the editing area to save your changes.'),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#control-sample-info"},"Control Sample Info"),"."),(0,l.kt)("h3",{id:"formatted-text"},"5. Formatted text"),(0,l.kt)("p",null,"A block containing any text in ",(0,l.kt)("a",{parentName:"p",href:"https://www.markdownguide.org/basic-syntax/"},"Markdown format"),"."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,"You can insert specific auto-fields into the text; their descriptions are\nprovided ",(0,l.kt)("a",{parentName:"p",href:"/settings/report-templates/report-templates#autofields"},"below"),"."),(0,l.kt)("h3",{id:"disclaimer"},"6. Disclaimer"),(0,l.kt)("p",null,"A block containing a disclaimer about the report\u2019s usage."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Text")," is a standard clinical liability disclaimer that can be edited.\nYou can insert specific auto-fields into the text; their descriptions are\nprovided ",(0,l.kt)("a",{parentName:"p",href:"/settings/report-templates/report-templates#autofields"},"below"),"."),(0,l.kt)("h4",{id:"autofields"},'Auto-Fields in "Formatted text" and "Disclaimer" blocks'),(0,l.kt)("p",null,"An auto-field is a specific marker in curly braces that, when inserted into a block\u2019s text, is automatically\nreplaced with a corresponding value in the report.\nFor example, inserting '{url}' into a block will result in the current page URL (essentially a link to the\nsample\u2019s page) appearing in the report.\nAuto-field values in a report will update automatically as patient or sample data changes \u2014 you don't need to\nregenerate the report."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},(0,l.kt)("em",{parentName:"strong"},"List of available auto-fields and their values:"))),(0,l.kt)("ul",null,(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{url}")," - current page URL;"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{ReportName}")," - name of the report (defined on the report template page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.code}")," - patient ID (set when the patient is created or edited);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.firstName}")," - patient\u2019s first name (set when the patient is created or edited);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.middleName}")," - patient\u2019s middle name (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.lastName}")," - patient\u2019s last name (set when the patient is created or edited);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.dateOfBirth}")," - patient\u2019s date of birth (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.age}")," - patient\u2019s age (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.sex}")," - patient\u2019s sex (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.diagnosis}")," - patient\u2019s diagnosis (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.dateOfDiagnosis}")," - date of diagnosis (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{patient.comments}")," - patient record comments (set on the patient page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.sampleName}")," - sample name (file name without extension; can be edited on the sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.sampleType}")," - sample type: NORMAL or TUMOR (selected when uploading the sample and can later\nbe changed either in the sample set editing window or by choosing a different type in the sample row for runs);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.sequencingType}")," - sequencing type (defined automatically; may depend on selected sequencing type\nand capture kit);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.sampleCollectionDate}")," - sample collection date (set on the sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.captureKit}"),' - capture kit reagents (defined automatically or selected when uploaded the sample and\ncan be changed on the "Parameters" tab");'),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.methodology}")," - sample preparation methodology (set on the sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.oncologicalDisease}")," - oncological disease diagnosed at time of sampling (set on the tumor sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.oncoStage}")," - oncological disease stage at time of sampling (set on the tumor sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.oncoStageDetails}")," - additional details on disease stage at time of sampling (set on the tumor sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.therapyLine}")," - therapy line at time of sampling (set on the tumor sample page);"),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("inlineCode",{parentName:"li"},"{sample.comments}")," - comments related to the sample (added on the sample page).")),(0,l.kt)("div",{className:"admonition admonition-tip alert alert--success"},(0,l.kt)("div",{parentName:"div",className:"admonition-heading"},(0,l.kt)("h5",{parentName:"div"},(0,l.kt)("span",{parentName:"h5",className:"admonition-icon"},(0,l.kt)("svg",{parentName:"span",xmlns:"http://www.w3.org/2000/svg",width:"12",height:"16",viewBox:"0 0 12 16"},(0,l.kt)("path",{parentName:"svg",fillRule:"evenodd",d:"M6.5 0C3.48 0 1 2.19 1 5c0 .92.55 2.25 1 3 1.34 2.25 1.78 2.78 2 4v1h5v-1c.22-1.22.66-1.75 2-4 .45-.75 1-2.08 1-3 0-2.81-2.48-5-5.5-5zm3.64 7.48c-.25.44-.47.8-.67 1.11-.86 1.41-1.25 2.06-1.45 3.23-.02.05-.02.11-.02.17H5c0-.06 0-.13-.02-.17-.2-1.17-.59-1.83-1.45-3.23-.2-.31-.42-.67-.67-1.11C2.44 6.78 2 5.65 2 5c0-2.2 2.02-4 4.5-4 1.22 0 2.36.42 3.22 1.19C10.55 2.94 11 3.94 11 5c0 .66-.44 1.78-.86 2.48zM4 14h5c-.23 1.14-1.3 2-2.5 2s-2.27-.86-2.5-2z"}))),"tip")),(0,l.kt)("div",{parentName:"div",className:"admonition-content"},(0,l.kt)("p",{parentName:"div"},"In Markdown, use two spaces at the end of a line to insert a line break."))),(0,l.kt)("h3",{id:"sign-place"},"7. Sign place"),(0,l.kt)("p",null,"A block with a designated space for the doctor's signature, which will appear as follows in the report:"),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(81736).Z,width:"500"})),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("h3",{id:"added-to-report"},"8. SNVs/Indels selected by user for reports"),(0,l.kt)("p",null,"A block containing the variants included in the report from the SNV Viewer page.\nIncluding variants in the report is described\nin ",(0,l.kt)("a",{parentName:"p",href:"/results/main/snvs-indels/variant-viewer#include-to-report"},"the corresponding section"),"."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Origin"),": somatic or germline.")),(0,l.kt)("h3",{id:"pinned-variants"},"9. Pinned SNVs/Indels"),(0,l.kt)("p",null,"A block containing the variants pinned in the SNV Viewer table.\nPinning variants is described in ",(0,l.kt)("a",{parentName:"p",href:"/results/main/snvs-indels/variant-viewer#pin-variant"},"the corresponding section"),"."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Origin"),": somatic or germline.")),(0,l.kt)("h3",{id:"suitable-variants"},"10. SNVs/Indels suitable for the specified conditions"),(0,l.kt)("p",null,"A block containing the variants matching conditions specified within it."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Origin"),": somatic or germline."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Conditions for including variants to the report"),": If the variants detected in the sample meet the specified\nconditions, they will be displayed in this report block. To create a condition,\nclick the button ",(0,l.kt)("img",{src:n(270).Z,width:"170"}),".\nThis will open the query builder, which is identical to the advanced variant search form on the SNV Viewer page.\nCreating conditions in the query builder are described\nin ",(0,l.kt)("a",{parentName:"li",href:"/results/main/snvs-indels/advanced-filtering#add-condition"},"the corresponding section"),"."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Use SNVs/Indels as potential findings"),": To include SNVs/Indels detected in the sample that meet the\nspecified conditions as ",(0,l.kt)("a",{parentName:"li",href:"/results/potential-findings"},"potential findings"),", activate the toggle switch.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/mutations-suitable-for-the-specified-conditions#snvs"},"Mutations Suitable For The Specified Conditions"),"."),(0,l.kt)("h3",{id:"suitable-cnvs"},"11. CNVs suitable for the specified conditions"),(0,l.kt)("p",null,"A block containing the copy number variations (CNVs) matching conditions specified within it."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"CNV region type"),": segment or bin. Read more about segments and\nbins ",(0,l.kt)("a",{parentName:"li",href:"/results/main/copy-number-variations/cnv-viewer#segments-and-bins"},"here"),"."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Conditions for including variations to the report"),": If the copy number variations detected in the sample\nmeet the specified conditions, they will be displayed in this report block. To define the condition,\nclick the button ",(0,l.kt)("img",{src:n(8735).Z,width:"170"}),".\nA window with CNV filtering parameters will open \u2014 these parameters are described\nin ",(0,l.kt)("a",{parentName:"li",href:"/results/main/copy-number-variations/cnv-filtering"},"the corresponding section"),":")),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(18473).Z,height:"640"})),(0,l.kt)("div",{className:"admonition admonition-note alert alert--secondary"},(0,l.kt)("div",{parentName:"div",className:"admonition-heading"},(0,l.kt)("h5",{parentName:"div"},(0,l.kt)("span",{parentName:"h5",className:"admonition-icon"},(0,l.kt)("svg",{parentName:"span",xmlns:"http://www.w3.org/2000/svg",width:"14",height:"16",viewBox:"0 0 14 16"},(0,l.kt)("path",{parentName:"svg",fillRule:"evenodd",d:"M6.3 5.69a.942.942 0 0 1-.28-.7c0-.28.09-.52.28-.7.19-.18.42-.28.7-.28.28 0 .52.09.7.28.18.19.28.42.28.7 0 .28-.09.52-.28.7a1 1 0 0 1-.7.3c-.28 0-.52-.11-.7-.3zM8 7.99c-.02-.25-.11-.48-.31-.69-.2-.19-.42-.3-.69-.31H6c-.27.02-.48.13-.69.31-.2.2-.3.44-.31.69h1v3c.02.27.11.5.31.69.2.2.42.31.69.31h1c.27 0 .48-.11.69-.31.2-.19.3-.42.31-.69H8V7.98v.01zM7 2.3c-3.14 0-5.7 2.54-5.7 5.68 0 3.14 2.56 5.7 5.7 5.7s5.7-2.55 5.7-5.7c0-3.15-2.56-5.69-5.7-5.69v.01zM7 .98c3.86 0 7 3.14 7 7s-3.14 7-7 7-7-3.12-7-7 3.14-7 7-7z"}))),"About Log2FC Thresholds")),(0,l.kt)("div",{parentName:"div",className:"admonition-content"},(0,l.kt)("p",{parentName:"div"},"The variation filter by log2FC thresholds (the logarithmic ratio of the observed copy number to the normal\ncopy number), offers the following options:"),(0,l.kt)("ul",{parentName:"div"},(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-1, Dup: \u22650.58 (chrX: \u22651, chrY: \u22651) (XY) Del: \u2264-1 (chrX: \u22640), Dup: \u22650.58 (chrX: \u22651.58, chrY: \u22650) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.9 (chrX: \u2264-3.8, chrY: \u2264-3.8), Dup: \u22650.55 (chrX: \u22650.94, chrY: \u22650.94) (XY) Del: \u2264-0.9 (chrX: \u22640.1), Dup: \u22650.55 (chrX: \u22651.55, chrY: \u2265-0.1) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.8 (chrX: \u2264-2.74, chrY: \u2264-2.74), Dup: \u22650.51 (chrX: \u22650.88, chrY: \u22650.88) (XY) Del: \u2264-0.8 (chrX: \u22640.2), Dup: \u22650.51 (chrX: \u22651.51, chrY: \u2265-0.23) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.7 (chrX: \u2264-2.11, chrY: \u2264-2.11), Dup: \u22650.46 (chrX: \u22650.82, chrY: \u22650.82) (XY) Del: \u2264-0.7 (chrX: \u22640.3), Dup: \u22650.46 (chrX: \u22651.46, chrY: \u2265-0.37) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.6 (chrX: \u2264-1.64, chrY: \u2264-1.64), Dup: \u22650.42 (chrX: \u22650.74, chrY: \u22650.74) (XY) Del: \u2264-0.6 (chrX: \u22640.4), Dup: \u22650.42 (chrX: \u22651.42, chrY: \u2265-0.55) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.5 (chrX: \u2264-1.27, chrY: \u2264-1.27), Dup: \u22650.37 (chrX: \u22650.66, chrY: \u22650.66) (XY) Del: \u2264-0.5 (chrX: \u22640.5), Dup: \u22650.37 (chrX: \u22651.37, chrY: \u2265-0.77) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.4 (chrX: \u2264-0.95, chrY: \u2264-0.95), Dup: \u22650.31 (chrX: \u22650.56, chrY: \u22650.56) (XY) Del: \u2264-0.4 (chrX: \u22640.6), Dup: \u22650.31 (chrX: \u22651.31, chrY: \u2265-1.04) (XX)"),(0,l.kt)("li",{parentName:"ul"},"Del: \u2264-0.3 (chrX: \u2264-0.67, chrY: \u2264-0.67), Dup: \u22650.24 (chrX: \u22650.45, chrY: \u22650.45) (XY) Del: \u2264-0.3 (chrX: \u22640.7), Dup: \u22650.24 (chrX: \u22651.24, chrY: \u2265-1.41) (XX)")),(0,l.kt)("p",{parentName:"div"},"Let\u2019s take threshold ",(0,l.kt)("em",{parentName:"p"},"Del: \u2264-0.7 (chrX: \u2264-2.11, chrY: \u2264-2.11), Dup: \u22650.46 (chrX: \u22650.82, chrY: \u22650.82) (XY) Del: \u2264-0.7 (chrX: \u22640.3), Dup: \u22650.46 (chrX: \u22651.46, chrY: \u2265-0.37) (XX)"),"\nas an example to explain how these filtering conditions work:"),(0,l.kt)("ul",{parentName:"div"},(0,l.kt)("li",{parentName:"ul"},"If the sample's chromosomal sex is determined","*"," as male (XY), the variations meeting the following threshold\nwill be included in the corresponding report\nblocks: ",(0,l.kt)("em",{parentName:"li"},"Del: \u2264-0.7 (chrX: \u2264-2.11, chrY: \u2264-2.11), Dup: \u22650.46 (chrX: \u22650.82, chrY: \u22650.82)"),".\nIf the sample's chromosomal sex is determined","*"," as female (XX), the variations meeting the following threshold\nwill be included in the corresponding report\nblocks: ",(0,l.kt)("em",{parentName:"li"},"Del: \u2264-0.7 (chrX: \u22640.3), Dup: \u22650.46 (chrX: \u22651.46, chrY: \u2265-0.37)"),"."),(0,l.kt)("li",{parentName:"ul"},"CNVs on autosomes with log2FC \u2264 -0.7 are classified as deletions.\nA log2FC below \u20130.7 corresponds to detecting one autosomal copy instead of two in the normal genome."),(0,l.kt)("li",{parentName:"ul"},"CNVs on autosomes with log2FC \u2265 0.46 are classified as duplications.\nThe threshold for duplications is calculated as follows: ",(0,l.kt)("em",{parentName:"li"},"log2FC = log",(0,l.kt)("sub",null,"2"),"((2+D)/2)"),", where ",(0,l.kt)("em",{parentName:"li"},"D"),' is the copy\nnumber "lost" at log2FC=-0.7, and ',(0,l.kt)("em",{parentName:"li"},"2")," is the normal number of sister chromatids in autosomes."),(0,l.kt)("li",{parentName:"ul"},"CNVs on the X chromosome are classified as deletions if log2FC \u2264 -2.11 for XY samples\nand log2FC \u2264 0.3 for XX samples; and as duplications if log2FC \u2265 0.82 for XY samples and log2FC \u2265 1.46 for XX samples."),(0,l.kt)("li",{parentName:"ul"},"CNVs on the Y chromosome are classified as deletions if log2FC \u2264 -2.11 for XY samples;\nand as duplications if log2FC \u2265 0.82 for XY samples and log2FC \u2265 -0.37 for XX samples."),(0,l.kt)("li",{parentName:"ul"},"Variations not meeting the thresholds - i.e., autosomal variations with -0.7 < log2FC < 0.46, X-chromosomal\nvariations with -2.11 < log2FC < 0.82 for XY samples or 0.3 < log2FC < 1.46 for XX samples, and Y-chromosomal\nvariations with \u20132.11 < log2FC < 0.82 for XY samples or log2FC < \u20130.37 for XX samples - do not pass the filter\nand are excluded from the report.")),(0,l.kt)("p",{parentName:"div"},"*The sample's chromosomal sex is determined by CNVkit from the relative copy number of the autosomes and sex\nchromosomes."))),(0,l.kt)("ol",{start:5},(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Use CNVs as potential findings"),": To include copy number variations detected in the sample that meet the\nspecified conditions as ",(0,l.kt)("a",{parentName:"li",href:"/results/potential-findings"},"potential findings"),", activate the toggle switch.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/mutations-suitable-for-the-specified-conditions#cnvs"},"Mutations Suitable For The Specified Conditions"),"."),(0,l.kt)("h3",{id:"immunotherapy-markers"},"12. Immunotherapy markers"),(0,l.kt)("p",null,"A block that reports the tumor mutation burden (TMB) value.",(0,l.kt)("br",null),"\nHigh TMB, more than 19 mutations per 1 Mb, may predict response to immunotherapy.\nLow TMB, less than 6 mutations per 1 Mb, may predict no susceptibility to immunotherapy."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#immunotherapy-markers"},"Immunotherapy Markers"),"."),(0,l.kt)("h3",{id:"clinical-trials"},"13. Clinical trials"),(0,l.kt)("p",null,"A block containing a table of ongoing clinical trials of various drugs, technologies or diagnostic approaches\nperformed in people with a certain phenotype from ",(0,l.kt)("a",{parentName:"p",href:"https://clinicaltrials.gov"},"the ClinicalTrials database"),"."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Phenotypes"),' - a list of phenotypes for which clinical trials should be displayed.\nPhenotype names must be separated by semicolons (e.g., "Glioma;Astrocytoma").'),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Phases"),": Phase 1, Phase 2, Phase 3, Phase 4.\nAfter selecting all relevant phases, click outside the editing area to save the changes.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#clinical-trials"},"Clinical Trials"),"."),(0,l.kt)("h3",{id:"acmg-sf"},"14. SNVs/Indels in ACMG SF genes"),(0,l.kt)("p",null,"A block displaying variants detected in the sample that are located in genes\nfrom ",(0,l.kt)("a",{parentName:"p",href:"https://www.ncbi.nlm.nih.gov/clinvar/docs/acmg/"},"the list of secondary findings (SF)")," recommended by\nthe American College of Medical Genetics and Genomics (ACMG). Specific mutations in these genes are known\nto cause disorders with defined phenotypes that are clinically actionable through established interventions.\nThe ACMG recommends reporting variants detected in any of these genes, as they are medically significant\nand may help guide future clinical management."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Origin"),": somatic or germline."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Frequency threshold for too frequent pathogenic variants"),": recommended default value = 0.03."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Use the most important variants for interpretation as potential findings"),":\nTo include SNVs/Indels detected in the sample that are located in genes from the ACMG SF list and associated\nwith the specified phenotype (",(0,l.kt)("a",{parentName:"li",href:"/results/acmg-sf-report#acmg-sf-content"},"Tier I variants"),")\nas ",(0,l.kt)("a",{parentName:"li",href:"/results/potential-findings"},"potential findings"),", activate the toggle switch."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Use the variants that require further analysis as potential findings"),":\nTo include SNVs/Indels detected in the sample that are located in genes from the ACMG SF list\nbut for which no match to the specified phenotypes or conditions could be determined\n(",(0,l.kt)("a",{parentName:"li",href:"/results/acmg-sf-report#acmg-sf-content"},"Tier II variants"),"), activate the toggle switch.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/acmg-sf-report"},"ACMG Secondary Findings Report"),"."),(0,l.kt)("h3",{id:"glioma-tier1"},"15. Glioma: Tier I variants"),(0,l.kt)("p",null,"A block displaying somatic single nucleotide variants (SNVs), copy number variations (CNVs), and structural\nvariations (SVs) detected in the sample and classified as Tier I somatic mutations.\nTier I includes mutations of strong clinical significance for glioma, supported by a high level of evidence\nand relevant for cancer diagnosis and treatment."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#tier-i"},"Variants of Strong Clinical Significance"),"."),(0,l.kt)("h3",{id:"glioma-tier2"},"16. Glioma: Tier II variants"),(0,l.kt)("p",null,"A block displaying somatic single nucleotide variants (SNVs), copy number variations (CNVs), and structural\nvariations (SVs) detected in the sample and classified as Tier II somatic mutations. Tier II includes mutations\nwith potential clinical significance for glioma \u2014 those that are clearly implicated in cancer development\nbut whose roles are not yet fully validated."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("h3",{id:"glioma-tier3"},"17. Glioma: Tier III variants"),(0,l.kt)("p",null,"A block displaying somatic single nucleotide variants (SNVs), copy number variations (CNVs), and structural\nvariations (SVs) detected in the sample and classified as Tier III somatic mutations. Tier III includes mutations\nthat have high gene product impact and are detected in genes associated with cancers other than glioma."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("h3",{id:"glioma-diagnosis"},"18. Glioma: Suggested diagnosis"),(0,l.kt)("p",null,"A block displaying a predicted glioma type defined for the sample.\nSuggested diagnosis and predicted survival times base on Tier I and Tier II mutations automated interpretation\nbased on published research. Suggestions were made under the assumption that the tumor DNA has been extracted\nfrom glioma, therefore, use this block in the report only if you have glioma sequencing samples. In case of\nuncertainty up to three most probable diagnosis suggestions are proposed."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#suggested-diagnosis"},"Suggested Diagnosis"),"."),(0,l.kt)("h3",{id:"suggested-drugs"},"19. Glioma: Suggested drugs"),(0,l.kt)("p",null,"A block displaying potentially effective and ineffective tumor-targeting drugs and corresponding biomarkers\ndetected in the sample."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#suggested-drugs"},"Suggested Drugs"),"."),(0,l.kt)("h3",{id:"mutation-details"},"20. Glioma: Mutations details"),(0,l.kt)("p",null,"A block with a description of mutations listed\nin ",(0,l.kt)("a",{parentName:"p",href:"/settings/report-templates/report-templates#glioma-tier1"},'"Glioma: Tier I variants"'),"\nand ",(0,l.kt)("a",{parentName:"p",href:"/settings/report-templates/report-templates#glioma-tier2"},'"Glioma: Tier II variants"')," blocks."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#mutations-details"},"Mutations Details"),"."),(0,l.kt)("h3",{id:"gene-panel-details"},"21. Glioma: Glioma genes panel details"),(0,l.kt)("p",null,"A block with information about the coverage of glioma-specific genes discovered in the sample.\nThe block includes the value of the fraction of the exonic part of the longest transcript covered by at least\n50 sequenced reads (50X) for the genes associated with glioma. The higher the percent of coverage, the more\ncompletely a transcript is sequenced."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#glioma-genes-panel-details"},"Glioma Genes Panel Details"),"."),(0,l.kt)("h3",{id:"glioma-germline-pathogenic-variants"},"22. Glioma: Germline pathogenic for gliomas"),(0,l.kt)("p",null,"The block displays germline single nucleotide variants (SNVs) detected in the sample that are classified as\npathogenic or likely pathogenic for gliomas. The following variants are included in the block:"),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},"Pathogenic (according to ClinVar);"),(0,l.kt)("li",{parentName:"ol"},"Likely pathogenic (according to ClinVar);"),(0,l.kt)("li",{parentName:"ol"},"Having high gene product impact;"),(0,l.kt)("li",{parentName:"ol"},"Having moderate gene product impact and frequency less than 10% in population;"),(0,l.kt)("li",{parentName:"ol"},"Rare (having frequency less than 5% in population).")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#pathogenic-or-likely-pathogenic-for-glioma"},"Pathogenic or Likely Pathogenic for Gliomas"),"."),(0,l.kt)("h3",{id:"no-glioma-germline-pathogenic-variants"},"23. Glioma: Germline pathogenic for any other diseases"),(0,l.kt)("p",null,"The block includes germline single nucleotide variants (SNVs) detected in the sample that are classified as\npathogenic or likely pathogenic and are associated with diseases other than gliomas."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("h3",{id:"glioma-associated-germline-pathogenic-variants"},"24. Glioma: Germline glioma associated"),(0,l.kt)("p",null,"The block displays germline single nucleotide variants (SNVs) detected in the sample that are associated\nwith gliomas according to published studies but were not included\nin ",(0,l.kt)("a",{parentName:"p",href:"/settings/report-templates/report-templates#glioma-germline-pathogenic-variants"},'the "Glioma: Germline pathogenic for gliomas" block'),"."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/glioma-report#glioma-associated"},"Glioma Associated"),"."),(0,l.kt)("h3",{id:"references"},"25. Glioma: Literature"),(0,l.kt)("p",null,"Block displaying links to articles, publications and books on glioma research."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," tumor."),(0,l.kt)("h3",{id:"cnv-results"},"26. Germline CNV: results"),(0,l.kt)("p",null,"The block presents the results of germline copy number variation (CNV) detection in the sample.\nIt includes a statement on whether any deviation from the normal copy number of a chromosome or\nchromosome arm was observed in the analyzed sample."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Show inferred sex"),": Based on CNVs detected in the sex chromosomes (X, Y), it is possible to infer\nthe patient's sex. To include the result of this inference in the report, enable the corresponding\ntoggle: ",(0,l.kt)("img",{src:n(47910).Z,width:"35"}),".")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/cnv-report/sample-cnv-report"},"CNV Report"),"."),(0,l.kt)("h3",{id:"cnv-interpretation"},"27. Germline CNV: interpretation"),(0,l.kt)("p",null,"The block presents an interpretation of the results of germline copy number variation (CNV) detection in\nthe sample, along with conclusions based on the findings. It includes:"),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},"A table listing chromosomes or chromosome arms where structural variations\n(copy number gains or losses) were detected;"),(0,l.kt)("li",{parentName:"ol"},"A karyogram-style plot indicating chromosome-level CNVs;"),(0,l.kt)("li",{parentName:"ol"},"Information on genome coverage depth.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required).")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/cnv-report/sample-cnv-report"},"CNV Report"),"."),(0,l.kt)("h3",{id:"onco-variants"},"28. Onco: Onco relevant SNVs/Indels selected by user for reports"),(0,l.kt)("p",null,"The block displays a table with information about clinically significant cancer-related variants included\nin the report from the SNV Viewer page. Including variants in the report is described\nin ",(0,l.kt)("a",{parentName:"p",href:"/results/main/snvs-indels/variant-viewer#include-to-report"},"the corresponding section"),".",(0,l.kt)("br",null),"\nOnco-relevant variants are those for which clinical guidelines exist, based on data from various\noncology-related medical communities (",(0,l.kt)("a",{href:"https://www.rosoncoweb.ru/"},"RUSSCO"),", ",(0,l.kt)("a",{href:"https://oncology-association.ru/"},"\u0410\u041e\u0420"),", ",(0,l.kt)("a",{href:"https://cr.minzdrav.gov.ru/"},"Clinical Recommendations of the Ministry of Health of the Russian Federation (\u041a\u0420 \u041c\u0417 \u0420\u0424)"),", ",(0,l.kt)("a",{href:"https://www.nccn.org/"},"NCCN"),", ",(0,l.kt)("a",{href:"https://www.esmo.org/"},"ESMO"),")."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/onco-genetic-testing-report#onco-relevant-variants"},"Onco-Relevant Variants"),"."),(0,l.kt)("h3",{id:"clinical-recommendations"},"29. Onco: Clinical Guidelines for onco relevant SNVs/Indels selected by user for reports"),(0,l.kt)("p",null,"The block displays clinical recommendations for onco-relevant variants included in the report from the SNV Viewer\npage. Including variants in the report is described\nin ",(0,l.kt)("a",{parentName:"p",href:"/results/main/snvs-indels/variant-viewer#include-to-report"},"the corresponding section"),".",(0,l.kt)("br",null),"\nThe block contains:"),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},"Selection fields for: (a) the oncological disease; (b) its stage; (c) stage details;\n(d) the therapy line used to treat the disease at time of sampling;\n(e) the mutation class (4 classes based on the mechanism that disrupts protein function);"),(0,l.kt)("li",{parentName:"ol"},"Clinical guidelines compiled from data provided by various oncology-related medical communities\n(",(0,l.kt)("a",{href:"https://www.rosoncoweb.ru/"},"RUSSCO"),", ",(0,l.kt)("a",{href:"https://oncology-association.ru/"},"\u0410\u041e\u0420"),", ",(0,l.kt)("a",{href:"https://cr.minzdrav.gov.ru/"},"Clinical Recommendations of the Ministry of Health of the Russian Federation (\u041a\u0420 \u041c\u0417 \u0420\u0424)"),", ",(0,l.kt)("a",{href:"https://www.nccn.org/"},"NCCN"),", ",(0,l.kt)("a",{href:"https://www.esmo.org/"},"ESMO"),"),\ncorresponding to: (a) the onco-relevant variant included in the report, and\n(b) the selected oncological disease, stage, stage details, and therapy line.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/onco-genetic-testing-report#clinical-guidelines"},"Clinical Guidelines"),"."),(0,l.kt)("h3",{id:"polygenic-traits"},"30. Polygenic traits"),(0,l.kt)("p",null,"The block displays results of polygenic trait prediction. Polygenic traits are characteristics that result\nfrom the combined action of many different genes, each contributing a small effect to the overall trait score."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Polygenic traits")," - a selection of traits whose prediction results will be shown in the report:")),(0,l.kt)("ul",null,(0,l.kt)("li",{parentName:"ul"},"Height;"),(0,l.kt)("li",{parentName:"ul"},"Weight;"),(0,l.kt)("li",{parentName:"ul"},"BMI (Body Mass Index);"),(0,l.kt)("li",{parentName:"ul"},"Obesity;"),(0,l.kt)("li",{parentName:"ul"},"Prostate cancer (will be displayed if the patient's sex is determined as male);"),(0,l.kt)("li",{parentName:"ul"},"Breast cancer (will be displayed if the patient's sex is determined as female);"),(0,l.kt)("li",{parentName:"ul"},"Coronary artery disease;"),(0,l.kt)("li",{parentName:"ul"},"Inflammatory bowel disease;"),(0,l.kt)("li",{parentName:"ul"},"Type 2 diabetes;"),(0,l.kt)("li",{parentName:"ul"},"Colorectal cancer.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/polygenic-report"},"Report on Polygenic Traits"),"."),(0,l.kt)("h3",{id:"clinvar-phenotype"},"31. SNVs/Indels by ClinVar phenotypes"),(0,l.kt)("p",null,"The block displays a phenotype from ",(0,l.kt)("a",{parentName:"p",href:"https://www.ncbi.nlm.nih.gov/clinvar/"},"the ClinVar database")," and\nassociated recommendations."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," any, tumor, normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"ClinVar Phenotypes")," - a table of phenotypes from the ClinVar database, for which the report will include\ninformation on pathogenic variants detected in the sample that are associated with increased risk of developing\nthese conditions. To add a phenotype, click the\nbutton ",(0,l.kt)("img",{src:n(21210).Z,width:"190"})," and fill out the form:",(0,l.kt)("ul",{parentName:"li"},(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("i",null,"MedGen ID")," - the phenotype ID from ",(0,l.kt)("a",{href:"https://www.ncbi.nlm.nih.gov/medgen/"},"the MedGen database"),' (e.g., "C0745103").'),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("i",null,"ClinVar name")," - phenotype name from ",(0,l.kt)("a",{href:"https://www.ncbi.nlm.nih.gov/clinvar/"},"the ClinVar database"),'. It must exactly match the ClinVar entry, for example: "Hypercholesterolemia, familial, 1". Use the ClinVar name if the MedGen ID is unknown, but the ID is preferred if available.',(0,l.kt)("br",null),"To add a phenotype, at least one of the fields \u201cMedGen ID\u201d or \u201cClinVar name\u201d must be filled out."),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("i",null,"Report name")," - the name of the phenotype as it will appear in the report."),(0,l.kt)("li",{parentName:"ul"},(0,l.kt)("i",null,"Recommendations")," - guidance related to the phenotype that may help the patient reduce the risk of developing the associated condition. Supports ",(0,l.kt)("a",{href:"https://www.markdownguide.org/basic-syntax/"},"Markdown formatting"),".",(0,l.kt)("br",null),"After filling in the required fields, click ",(0,l.kt)("img",{src:n(54063).Z,width:"160"}),". You can add as many phenotypes as needed in this way."))),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Origin"),": somatic or germline."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Frequency threshold for extremely rare pathogenic variants"),": recommended default value = 0,01."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Frequency threshold for too frequent pathogenic variants"),": recommended default value = 0,15."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Reliability threshold"),": recommended default value = 0,01.\nThe confidence of variant detection is calculated as: ",(0,l.kt)("i",null,"(1 - Bin(n; m; p; 1))"),",",(0,l.kt)("br",null),"\nwhere ",(0,l.kt)("i",null,"Bin(n; m; p; 1)")," is the binomial probability of observing the variant exactly ",(0,l.kt)("i",null,"n")," times\namong ",(0,l.kt)("i",null,"m")," individuals (patient samples) in the population;",(0,l.kt)("br",null),(0,l.kt)("i",null,"n")," \u2013 the number of individuals in the population (patient samples) in which the given variant was detected;",(0,l.kt)("br",null),(0,l.kt)("i",null,"m")," \u2013 the total number of individuals (patient samples) in the population;",(0,l.kt)("br",null),(0,l.kt)("i",null,"p")," \u2013 the probability of observing the variant in the human population (i.e., the total allele frequency from ",(0,l.kt)("a",{href:"https://gnomad.broadinstitute.org/news/2020-10-gnomad-v3-1/"},"the gnomAD 3 database"),"). If no population frequency data is available, a default value of p = 0.001 is used.",(0,l.kt)("br",null),"The values for ",(0,l.kt)("i",null,"n")," and ",(0,l.kt)("i",null,"m")," are taken from ",(0,l.kt)("a",{href:"/settings/custom-annotations#define-annotation-type"},"the user-provided frequency database"),". If no such database is uploaded, the reliability threshold will not be applied."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"The heading of the phenotypes list")," - header for the list of conditions associated with detected pathogenic\nor likely pathogenic variants."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Heading if no pathogenic variants found")," - text shown when no pathogenic variants increasing risk of\ninvestigated conditions are detected in the sample."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description of the genetic variants found")," - title for the table listing detected pathogenic or likely\npathogenic genetic variants associated with increased risk of the investigated conditions."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"The heading of the recommendations")," - header shown in the detailed report section containing diagnostic\nor follow-up recommendations (if any are available for the condition in the report template)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Recommendations for the patient")," - general recommendation text for the patient."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Information for the doctor")," - explanation text on how the report was generated.")),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Example block in the report:")," ",(0,l.kt)("a",{parentName:"p",href:"/results/variants-by-phenotypes"},"ClinVar Phenotype Report"),"."),(0,l.kt)("h3",{id:"pharmacogenetics"},"32. Pharmacogenetic"),(0,l.kt)("p",null,"The block displays the results of pharmacogenetic analysis \u2014 an interpretation of the patient's genetic data\naimed at predicting their individual response to medications."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Applicable to samples:")," normal."),(0,l.kt)("p",null,(0,l.kt)("strong",{parentName:"p"},"Editable fields:")),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Name")," \u2013 the section title (required)."),(0,l.kt)("li",{parentName:"ol"},(0,l.kt)("em",{parentName:"li"},"Description")," \u2013 the text displayed below the title.")),(0,l.kt)("h2",{id:"edit-template"},"Edit report template"),(0,l.kt)("p",null,"In the report template, you can edit its fields (\u201cName,\u201d \u201cActive,\u201d \u201cReport title,\u201d \u201cReport description\u201d)\nas well as the blocks added to it."),(0,l.kt)("div",{className:"admonition admonition-note alert alert--secondary"},(0,l.kt)("div",{parentName:"div",className:"admonition-heading"},(0,l.kt)("h5",{parentName:"div"},(0,l.kt)("span",{parentName:"h5",className:"admonition-icon"},(0,l.kt)("svg",{parentName:"span",xmlns:"http://www.w3.org/2000/svg",width:"14",height:"16",viewBox:"0 0 14 16"},(0,l.kt)("path",{parentName:"svg",fillRule:"evenodd",d:"M6.3 5.69a.942.942 0 0 1-.28-.7c0-.28.09-.52.28-.7.19-.18.42-.28.7-.28.28 0 .52.09.7.28.18.19.28.42.28.7 0 .28-.09.52-.28.7a1 1 0 0 1-.7.3c-.28 0-.52-.11-.7-.3zM8 7.99c-.02-.25-.11-.48-.31-.69-.2-.19-.42-.3-.69-.31H6c-.27.02-.48.13-.69.31-.2.2-.3.44-.31.69h1v3c.02.27.11.5.31.69.2.2.42.31.69.31h1c.27 0 .48-.11.69-.31.2-.19.3-.42.31-.69H8V7.98v.01zM7 2.3c-3.14 0-5.7 2.54-5.7 5.68 0 3.14 2.56 5.7 5.7 5.7s5.7-2.55 5.7-5.7c0-3.15-2.56-5.69-5.7-5.69v.01zM7 .98c3.86 0 7 3.14 7 7s-3.14 7-7 7-7-3.12-7-7 3.14-7 7-7z"}))),"note")),(0,l.kt)("div",{parentName:"div",className:"admonition-content"},(0,l.kt)("p",{parentName:"div"},"All changes to the template will be applied to samples if they were uploaded after the changes were made,\nor if any analysis stage was reprocessed for them after the changes."))),(0,l.kt)("h3",{id:"template-block"},"Template block"),(0,l.kt)("p",null,'Added template block looks like this (example: the "Sample info" block):'),(0,l.kt)("p",{align:"center"},(0,l.kt)("img",{src:n(19312).Z,width:"900"})),(0,l.kt)("p",null,"The block name is written at the top, and information about its content is given in the main part."),(0,l.kt)("h4",{id:"move-block"},"Move a block in a template"),(0,l.kt)("p",null,"To lift the added block up in the template (above the previous block),\nclick on ",(0,l.kt)("img",{src:n(51363).Z,width:"25"}),", and to bring it down - click on ",(0,l.kt)("img",{src:n(92732).Z,width:"25"}),"."),(0,l.kt)("h4",{id:"edit-block"},"Edit template block"),(0,l.kt)("p",null,"To edit the added block,\nclick on ",(0,l.kt)("img",{src:n(26803).Z,width:"23"}),", edit, and then click on ",(0,l.kt)("img",{src:n(37321).Z,width:"170"})," to save changes. To cancel your changes, click on ",(0,l.kt)("img",{src:n(82901).Z,width:"150"}),"."),(0,l.kt)("h4",{id:"delete-block"},"Delete template block"),(0,l.kt)("p",null,"To delete the added block, click on ",(0,l.kt)("img",{src:n(89284).Z,width:"23"}),", and then click on ",(0,l.kt)("img",{src:n(69558).Z,width:"160"})," in the appeared confirmation window. To cancel deletion, click on ",(0,l.kt)("img",{src:n(82901).Z,width:"150"}),"."),(0,l.kt)("h2",{id:"export-template"},"Export report template"),(0,l.kt)("p",null,"The export option is available on the template page if at least one block has been added to the saved template.\nTo export a report template in JSON format,\nclick on ",(0,l.kt)("img",{src:n(51069).Z,width:"160"}),"."),(0,l.kt)("h2",{id:"import-template"},"Import report template"),(0,l.kt)("p",null,"To import a report template into the system,\nclick on ",(0,l.kt)("img",{src:n(95244).Z,width:"200"}),' on the "Report templates" page. Drag and drop JSON template file into the opened window, or click on the window to open File Browser. Once the template has uploaded, click on ',(0,l.kt)("img",{src:n(5413).Z,width:"180"}),"."),(0,l.kt)("h2",{id:"delete-template"},"Delete report template"),(0,l.kt)("p",null,'To delete a report template, hover over the template row on the "Report templates" page and\nclick on ',(0,l.kt)("img",{src:n(21622).Z,width:"20"}),", and then click on ",(0,l.kt)("img",{src:n(69558).Z,width:"160"})," in the appeared confirmation window. To cancel deletion, click on ",(0,l.kt)("img",{src:n(82901).Z,width:"160"}),"."),(0,l.kt)("h2",{id:"report-generation"},"About a report generation"),(0,l.kt)("p",null,"A report is generated for a sample if the following conditions are met:"),(0,l.kt)("ol",null,(0,l.kt)("li",{parentName:"ol"},"The sample type matches the type to which the report template is applicable (Any, Tumor, or Normal)."),(0,l.kt)("li",{parentName:"ol"},'The sample analysis was successfully completed (that is, all stages of the analysis have the status "Complete").'),(0,l.kt)("li",{parentName:"ol"},'The results necessary for the report generation were obtained for the sample. If the template includes blocks that\ndepend on certain stages of analysis (blocks with SNVs/indels, copy number variations, or structural variations), then\nthe report generation will depend on the completion of at least one of the corresponding stages of the sample analysis.\nReport blocks that depend on the results of stages turned off in the workflow will not be included in the report. For\nexample, if the report template includes the "Germline CNV: results" block, then this block generation will depend on\nthe successful completion of the "Copy number variations discovery" stage.'),(0,l.kt)("li",{parentName:"ol"},"The report template is active."),(0,l.kt)("li",{parentName:"ol"},"The report template has at least one added block."),(0,l.kt)("li",{parentName:"ol"},"The report template was created before the sample was processed.")),(0,l.kt)("p",null,'The report is divided into sections and blocks. If you have not added any "Section" blocks to the template,\nthen all blocks will be automatically numbered according to their location in the template (1, 2, 3, ...).\nThe sections added to the template are also numbered according to their location in the template (1, 2, 3, ...).\nThe blocks included in the section are numbered according to their location in the template and depending on the\nsection number (1.1, 1.2, 1.3, ...). If the block was not included in the final report, then it is not taken into\naccount in the numbering.'))}c.isMDXComponent=!0},12233:function(e,t){t.Z="data:image/png;base64,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"},69558:function(e,t){t.Z="data:image/png;base64,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"},21622:function(e,t){t.Z="data:image/png;base64,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"},54063:function(e,t){t.Z="data:image/png;base64,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"},95244:function(e,t){t.Z="data:image/png;base64,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"},91836:function(e,t){t.Z="data:image/png;base64,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"},47910:function(e,t){t.Z="data:image/png;base64,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"},37321:function(e,t){t.Z="data:image/png;base64,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"},49072:function(e,t,n){t.Z=n.p+"assets/images/add_new_block-2c05dc0f42b17f299b60ef9d46754623.png"},21210:function(e,t){t.Z="data:image/png;base64,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"},4426:function(e,t,n){t.Z=n.p+"assets/images/add_template_page-4e909cdcb31d86f1eacb7b6f6f29d118.png"},19312:function(e,t,n){t.Z=n.p+"assets/images/block_example-cdfb122ce422a84bae290efe26f34a2c.png"},82901:function(e,t){t.Z="data:image/png;base64,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"},18473:function(e,t,n){t.Z=n.p+"assets/images/cnvs_conditions_form-9f8baf365ba2b2da914024b8047a88d1.png"},89284:function(e,t){t.Z="data:image/png;base64,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"},92732:function(e,t){t.Z="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAB0AAAAWCAYAAAA8VJfMAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAAEnQAABJ0Ad5mH3gAAACeSURBVEhLY3j39d9/euNRS2mKRy2lKR68ljZ2TgZjbHLImFh1BC3dvv/kfxE5TTDWt3TBqgaEvUPi4eou33qMVQ0ME+XTtPxKvBYjWwhio8ujY6IsBbkcFGzIFoPEQJhUC0GY6ISEzWJyLARhoi0FYXSLybEQhEmyFIaRLQbFNzY1+DBZloLwnCXriMoe2DDZllKCRy2lKR4plv77DwC2KkdTlhp2lwAAAABJRU5ErkJggg=="},26803:function(e,t){t.Z="data:image/png;base64,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"},8735:function(e,t,n){t.Z=n.p+"assets/images/edit_condition-d338a8fe0ee3a877b02e89ad6db02791.png"},51069:function(e,t,n){t.Z=n.p+"assets/images/export-70e731c6c3502d64dad2cebff030bcff.png"},5413:function(e,t){t.Z="data:image/png;base64,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"},270:function(e,t,n){t.Z=n.p+"assets/images/query_builder-6bdd5f321fd07dc1c08121e7dae8c56b.png"},68687:function(e,t,n){t.Z=n.p+"assets/images/rt_page-0ae12af9ca693f1e81a31b4ecc7191c4.png"},11258:function(e,t){t.Z="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAOIAAAA3CAYAAAAR45ZLAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAAEnQAABJ0Ad5mH3gAAAYkSURBVHhe7Z3PaxtHFMfzH4X8DU0vOrc0lx4NpempJx/dnkoaQ2sTSNMfxGkbfAgmlCJCakLBFCNak+QQRGNESOsSy2t5pVVkaVdavc53d2Y1K69cx9VaS/J98LnMzjwZ4o/fvNlV9pwwGIyZx4lEHA6HhJBTcpI4VkST6OBlKD9sHspHP3ry9qIrFz5tyPkFQsg4cAOOwBU4A3dOImSmiGZhGIby5XqH4hFySuAOHIJLxwl5REQzeXs3kEtfNTOTE0JeDbgEpybJmBLRTHqqFqC8ZiUkhJwOOAW3smRMRDQXB4OBXLrOSkhIHsAtODYuYySiLeEX99uZCQgh0wGOjcuYiIhm0vECufBJ9mJCyHSAY3DNHOBEIhoJYeit315mLiSETBe4BueMjImIQRDIh9+zNyTkLIBrcC4lIsz0fV8uXj3IXEQImS5wDc6ZXvEcjOz3+9Lr9dgfEnJGwDU4B/fgYCQiSmS3281cQAjJBzhntqeJiIeHh5mTCSH5AOcSEU1/2Ol0MicTQvIBzpk+kSISMiMoIiEFgCISUgAoYoEo3WzL/FrMxzf5jZc3CYpYAN4r+1LrRI8ZpqMzkNU7FPJNgCLOmNL9QDztHaLnDyOS6A9k7Xb2WvL6QBFniitrjhbOV9XPEq50x5edML7Ue877uq87FHGmdKTSnSzbcnUgtbqial1basvK9kC8frxOwqF4bl/KZf2Q/jddedSJq+pOdewbNGtKbl1xq1stPe7K/Gagtsa6CiNfazDKR84EijhTPFl3499/6Yey/l+//EtKXKuXjLaxumqKDKVyD/NcWX2hh9qBzFvr557oyaGqvkvx3MVn1jZYSWjnqz30krUkXyjijBnvEaWvKtk/gawr4+YiWUa8vzWIRQlDKZtDHMipq6q80M8Ibw70QCgba2a9Jb2aV8LYPfPZSrrH7XhsoSnLRk7Vn66M/QwkHyhiAcCpabVlVSYTqkLVHne0IJNoSrmh5zs9PXYoj/x4aOeJrmq31LY0HpJqJZZ4+bn+TNeXuSRfen110x4neUERi8QNT5YrvlTqYXqLuDXaIpZudmR1uy81N+71RvNUJCIelaz0UFdJtS1d0XOSgyJsSXXvaDBRe6h/NpIrFLGo2P2g7vWybnXs1JWUbT1giXj+QV960aDaxt4anc72/h4d/BwnoqH6u85HcoUizpJyoE8xQ6k8OHo9OUjpBrJo3+po+DJv9W7JuC2idSJbe9yValQ5h/LI+pwVc6ij8h2//SV5QxFnihFERSeQr63H2tA37phbFEqw0kJbNnTl855Z/z5Lo34uLWJDFrZ18r4W2u/LsnW9VDGHOkOp3Lee4LntSw1/ILo4yR3NJ/lBEWfMZdW7xVtIHUqanhEwipEkSd+nxhwnvsfoqLnJ/DERz98NxBRLRErgCE9V01E/6Lkqp2P1p+qPw2JqPskLijhz4hvqO6aqWdHrjN1YV33jhjsSB9FzfFk1W9hxEa0qil5x4659TaNyluvpnAhP5V2+kTGf5AJFLBD2ty/G7yHamHnT/YZGUy6f4LNJPlBEQgoARSSkAFBEQgoARSSkAFBEQgoARSSkAFBEQgrARBH5EhpCzga4NlHEi1ezFxFCpgtcmyjiByt8PyIhZwFcmyjit79O8/EpQsgk4FpKRPu1bH/tttgnEpIzcAyupV7LZkTESxM9z5MrP2cvJoRMhyvKMbh25EWl5tXd7XZbXNeVd69lJyCE/D/gFhyDa6lXd+NF+naf2Gq1ZOvpvrz1eXYiQsjpgFNwC47Z/SEcjES0t6emKv7xpyPvXNvPTEgIeTXgEpwy1dDelqZENFURDST2rwcHB+I4jnz2k8MDHEJOCdyBQ3AJTsEtOGaqYSIi/osEI6PpFc0W1ci4/bwu13/Zk7nvHFVe9ykmIROAG3AErsAZuGMkNFtSuzeEe4hERABDUS6NjLAXpXR/fz9Ktre3J/V6XXZ3dwkhE4AjcAXOwB04BJeMhHDM9IYpERFZMqKEYj8Lk5Gs0WhEiY2YhJA0xg+4AmfgDhyCS5MkRCQiImwZUTqxj0VTCZORDFYjcbPZJIRMAI7AFTgDd+AQXIJTWRKKiPwLFYOD0RjvLYYAAAAASUVORK5CYII="},88928:function(e,t,n){t.Z=n.p+"assets/images/saved_template-b2e40fe555f532a9fc51b688e117fc99.png"},81736:function(e,t){t.Z="data:image/png;base64,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"},51363:function(e,t){t.Z="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABsAAAAZCAYAAADAHFVeAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAAEnQAABJ0Ad5mH3gAAACgSURBVEhLY3j39d9/euFRy6iCRy2jCh61DI4bOyf/n7NkHVY5Qpgky9LyK/+LyGmCMchSbGrwYaIt8w6Jh1sEwyDLsanFhYmyDNkifUsXMCbHQoKWoVsEErt86zFZFuK1DNkiEBtZDmQhNofgwzgt277/JE6LYBjdQhAfmzoYxuszUIojlOpAFhCjDoSJSiDUwqOWUQWPWkYVTEfL/v0HABYN1XUJtVdqAAAAAElFTkSuQmCC"}}]);